Report

Beyond the lab: immuno-oncology

Read this in-depth analyses and insights from leading experts in the field focusing on treatments, new technologies and engineered bacteria.

Dear readers,

Welcome to our comprehensive report dedicated to the latest advancements and breakthroughs in immuno-oncology. Download now to find exclusive interviews, insightful articles, and in-depth analyses from leading experts in the field.

Expert insights from:

  • Dr Catherine Pickering, CEO of iOnctura
  • Dr Espen Basmo Ellingsen, University of Oslo

We explore advancements across multiple fronts in cancer treatment. From the discovery of IOA-289, an autotaxin inhibitor with potential in pancreatic cancer therapy, to the development of Spectra, an open-source computational method revolutionising single-cell transcriptomic data analysis, the report showcases cutting-edge research and innovative approaches. Insights into macrophage phenotype optimisation for improved immunotherapy outcomes and novel stem cell extraction technologies further enrich the report’s offerings. Additionally, mRNA therapies for glioblastoma demonstrate the evolving landscape of immune-based cancer treatments. 

Download now to read more about:

  • Combining autotaxin and TGF-β inhibitors in cancer
  • New insights to improve immunotherapy treatments
  • The promise of NK cell therapeutics
  • Macrophage phenotype insights
  • New technology optimising mesenchymal stem cell extraction
  • Cancer-killing T cells enhanced by engineered bacteria.

We are committed to providing you with the highest quality content, and we believe that this report will deliver a different perspective on the topics covered.

Thank you for your continued support.

Sincerely,

Taylor Mixides

Editor

Drug Target Review

Interested? Please register your details in the box to receive this exclusive content.

This Beyond the Lab report is brought to you in association with:

Sino Biological Logo